We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HDL Announces Acquisition of Harris Scientific

By LabMedica International staff writers
Posted on 31 May 2011
Health Diagnostic Laboratory Inc. More...
(HDL, Inc.; Richmond, VA, USA), a College of American Pathologists (CAP) accredited laboratory specializing in health management, announced that it will expand its comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases through the acquisition of Harris Scientific, Inc., a company providing omega-3 fatty acid testing.

Dr. William Harris (of Harris Scientific) will join HDL to expand his work in fatty acid analysis, and to enhance HDL's fatty acid panel of tests. This panel includes measurement of the level of omega-3, omega-6, cis-monounsaturated, saturated and transfatty acids in erythrocyte membranes.

By reducing inflammation, blood clotting, and improving membrane function, omega-3's can reduce risk of heart disease–including fatal heart attacks and heart failure–both in persons with a history of cardiovascular disease and in healthy individuals.

Tonya Malory, CEO and cofounder of HDL commented, "With Dr. Harris joining HDL, the company will be positioned to establish the Fatty Acid profile as the worldwide standard for tracking and optimizing omega-3 status which will result in reduced morbidity and mortality from today's chronic diseases."

Related Links:

Health Diagnostic Laboratory Inc.



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.